Tuesday, 10 August 2021

SkyCell launches annual sustainability report; commits to reach carbon neutral by 2040

According to the Journal of Cleaner Production, the pharmaceutical industry’s emission intensity is 55% higher than that of the automotive industry, signalling the desperate need for action 

SkyCell, the leading manufacturer of innovative pharma containers, is publicly announcing its sustainability and carbon neutrality goals and its progress towards them in its first annual Sustainability Report. The Swiss company, whose containers’ CO2 emissions are already about half the industry standard due to technological innovation and sustainability-focused product design, wants to lead the way to a more sustainable pharmaceutical supply chain and help counter the mounting climate crisis. Through its ambitious goals focused on climate, circularity, and cooperation, SkyCell commits to reaching fully carbon neutrality by 2040.  

Since its creation in 2012, SkyCell has held Environmental, Sustainability and Governance (ESG) at the core of its operations. As part of its commitment to the UN Sustainable Development Goals and the Paris Agreement, SkyCell is strengthening its efforts to reduce greenhouse gasses by setting itself ambitious goals. 
These include running solely on renewable energies by the end of 2021 and reducing direct emissions from SkyCell’s operations, and indirect ones related to the energy used for the company’s activities, by 50% by 2030. SkyCell’s ultimate goal is to achieve full carbon neutrality by 2040, with minimal use of carbon certificates.* To further help the company reach its ambitious goal, SkyCell is exploring technological innovation through various partnerships such as with Swiss start-up, Airborn Fuels, to produce jet fuel out of CO2 and renewable energy.

To tackle unavoidable emissions - such as those produced during the manufacturing of SkyCell products - SkyCell has acquired carbon dioxide removal and carbon offset certificates from Climeworks and the United Nations’ REDD+ forest protection and reforestation projects in Indonesia, Peru, and Brazil.

SkyCell also embraces the circular economy, meaning its products are 100% owned by them and leased, not sold, to clients, which minimises resource depletion and ensures no landfill is created as a result of SkyCell’s operations. To minimise waste and energy consumption further, SkyCell uses more than 90% recyclable materials and repairs containers to ensure their longevity, rather than throwing old ones away in favour of building new ones. For the parts that can’t be reused or repaired, the aim is to recycle 90% of their total weight. The rest will go to high-quality and strictly-regulated Swiss waste incineration plants, which produce heat and electricity for the Swiss energy system.

As members of the HOPE Consortium, a collective of related industry partners committed to working together to distribute vaccines globally, SkyCell is committed to facilitating the whole cold chain process so that those in need of vital life-saving medicines and vaccines receive them on time and in pristine condition. 

Nico Ros, CTO and Co-Founder of SkyCell, said: “The past year has challenged us, and the planet, in ways that we never thought possible. As we move decisively into a post-COVID world, we must not forget the duties that we have to safeguarding our planet from the devastating effects of climate change. People and corporations must now decide how they can contribute to preventing the worst man-made disasters. The planet and society are the key to our vision at SkyCell. At the end of our supply chain, there is always a human being who depends not only on a safe delivery of medicine but also on a sustainable one. This report is an ideal companion in understanding how SkyCell is helping to secure a greener future for us all.”


More top stories you might be interested in.....

Follow this site here.

No comments: